Asacol (mesalamine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved August 1997

Specific Treatments:

ulcerative colitits

Find Related Trials for The Following Conditions

General Information

Asacol (mesalamine) was approved by the Food and Drug Administration in August 1997. Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Side Effects

Side effects include headaches, abdominal pain, eructation, and nausea.